Skip to main content

Table 4 Results during follow-up after discharge among those who recovered by study group

From: Effects of unconditional cash transfers on the outcome of treatment for severe acute malnutrition (SAM): a cluster-randomised trial in the Democratic Republic of the Congo

Parameters

Intervention arm

Control arm

P valuea

Number (%)

707

(51.7)

660

(48.3)

Relapse to MAM, n (%)b

91

(12.9)

292

(44.2)

<0.001

 Relapse to WHZ < –2 and ≥ –3

58

(8.2)

201

(30.5)

 

 Relapse to MUAC <125 mm and ≥115 mm

57

(8.1)

279

(42.3)

 

Relapse to SAM, n (%)c

24

(3.4)

73

(11.1)

<0.001

 Relapse to WHZ < -3

8

(1.1)

30

(4.5)

 

 Relapse to MUAC <115 mm

0

(0.0)

22

(3.3)

 

 Relapse to oedema

16

(2.3)

26

(3.9)

 

Length/height change (mm/week), mean (SD)

1.35

±1.33

1.45

±0.18

0.602

Weight change (gram/kg/day), mean (SD)d

0.86

±0.66

0.46

±0.72

<0.001

MUAC change (mm/day), mean (SD)

0.060

±0.05

0.012

±0.04

<0.001

HAZ change (Z-score/month), mean (SD)

–0.018**

±0.18

0.003

±0.15

0.502

WAZ change (Z-score/month), mean (SD)d

0.08**

±0.15

–0.01

±0.15

<0.001

WHZ change (Z-score/month), mean (SD)d

0.13**

±0.24

–0.03**

±0.22

0.006

BMIZ change (Z-score/month), mean (SD)d

0.14**

±0.28

– 0.02*

±0.23

0.017

MUACZ-age change (Z-score/month), mean (SD)

0.132**

±0.14

– 0.001

±0.14

<0.001

MUACZ-ht change (Z-score/month), mean (SD)

0.141**

±0.14

0.005

±0.15

<0.001

  1. *P < 0.05 for change in standardised anthropometric parameter different from zero
  2. **P < 0.001 for change in standardised anthropometric parameter significantly different from zero
  3. aComparisons between arms were made by using linear mixed-effects models for continuous outcomes, whereas mixed-effects logistic regression models were used for proportions, with health centre as random effects
  4. bRelapse to MAM was defined as the development of a WHZ < –2.0 and ≥ –3.0 (WHO Growth Standards 2006) or MUAC <125 mm and ≥115 mm (without bilateral oedema) at least once during the monthly follow-up visits without the child developing SAM criteria during any other follow-up visit
  5. cRelapse to SAM was defined as development of a WHZ < −3.0 (WHO Growth Standards 2006) or MUAC <115 mm or presence of bilateral oedema at least once during the monthly follow-up visits
  6. dChildren with oedema were excluded from the analysis of parameters including weight